Picture of Navamedic ASA logo

NAVA Navamedic ASA Share Price

0.000.00%
no flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m-20.02%
3m-20.01%
6m-24.85%
1yr-44.92%
Volume Change (%)
10d/3m+87.57%
Price vs... (%)
52w High-40.25%
50d MA-18.35%
200d MA-27.54%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)10.79
PEG Ratio (f)0.29
EPS Growth (f)60.04%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.71
Price to Tang. Bookn/a
Price to Free Cashflow132.86
Price to Sales0.77
EV to EBITDA8.44

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.69%
Return on Equity10.82%
Operating Margin8.74%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueNOKm188.75209.88278.44382.13512536.7626.522.72%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+3396.73-40+86.02+57.77n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Navamedic ASA EPS forecast chart

Profile Summary

Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
November 4th, 2002
Public Since
March 31st, 2006
No. of Shareholders
1,344
No. of Employees
45
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
no flag iconOslo Stock Exchange
Shares in Issue
17,432,777

NAVA Share Price Performance

Upcoming Events for NAVA

Similar to NAVA

Picture of Arctic Bioscience AS logo

Arctic Bioscience AS

no flag iconOslo Stock Exchange

Picture of Photocure ASA logo

Photocure ASA

no flag iconOslo Stock Exchange

Picture of Vistin Pharma ASA logo

Vistin Pharma ASA

no flag iconOslo Stock Exchange

FAQ